Researchers at the University of Cambridge have signed an agreement with the Mongolian government which will see them explore the legacy of the legendary figure Genghis Khan - or Chinggis Khaan as he is known in Mongolia.
Researchers have developed an adaptable algorithm that could improve road safety by predicting when drivers are able to safely interact with in-vehicle systems or receive messages, such as traffic alerts, incoming calls or driving directions.
Researchers have discovered that misreading of therapeutic mRNAs by the cell’s decoding machinery can cause an unintended immune response in the body. They have identified the sequence within the mRNA that causes this to occur and found a way to prevent ‘off-target’ immune responses to enable the safer design of future mRNA therapeutics.
Per capita access to hospitals, mental health services, and further education facilities in German towns and cities – primarily in the former GDR – now outstrip equivalent areas in England, often several times over, according to research.
Researchers have discovered magnetic monopoles – isolated magnetic charges – in a material closely related to rust, a result that could be used to power greener and faster computing technologies.
Four researchers are among the UK’s “most promising research leaders” who will benefit from £101 million from UKRI to tackle major global issues and commercialise their innovations.
Researchers find that babies don’t begin to process phonetic information reliably until seven months old which they say is too late to form the foundation of language.
One in 200 newborns is admitted to a neonatal unit with sepsis caused by a bacteria commonly carried by their mothers – much greater than the previous estimate, say Cambridge researchers. The team has developed an ultra-sensitive test capable of better detecting the bacteria, as it is missed in the vast majority of cases.
An international team has shown that the injection of a type of stem cell into the brains of patients living with progressive multiple sclerosis (MS) is safe, well tolerated and has a long-lasting effect that appears to protect the brain from further damage.
The facility, based at the Milner Therapeutics Institute, will support the discovery of new medicines and diagnostics for chronic diseases by applying advanced biological and technological tools, including CRISPR gene editing.
